Skip to content
WeighLab
Menu
Ranked #308 · Grade C

Midi Health review

Midi Health is a telehealth platform built around midlife women's hormone health (menopause, HRT) that also runs a genuine GLP-1 weight-management track with its own dedicated pricing page.

Visit Midi Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$166/mo (0.5 mg dose, plus a separate fee, compounded)
Tirzepatide
$210/mo (2.5 mg dose, plus a separate fee, compounded)
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$1,992

Tirzepatide · modeled / year

$2,520

Pricing verified August 2026

The Index scorecard

Midi Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month49/100
Price Transparency20/100
Nationwide Access86/100
Formulation Options66/100
Clinical Oversight77/100
Contract Flexibility55/100

Where the value is

  • No membership fee — the site states outright 'You only pay for your care and your medications'
  • Medication price already includes shipping and supplies, so the listed number is closer to the true out-of-pocket cost than sites that add fees later
  • Dose-tiered pricing is published transparently: compounded semaglutide $165.90-$355.00/mo, compounded tirzepatide $210.00-$434.00/mo depending on dose
  • Offers both compounded and brand-name (Wegovy/Zepbound via patient's own pharmacy) paths, plus sublingual (oral) formulations as an alternative to injections
  • Clinicians there are already treating hormonal health, so a patient can address menopause and weight in one visit rather than juggling two telehealth accounts

The tradeoffs

  • The advertised 'Weekly doses start at $34' teaser on the weight-management overview page refers to microdosing, not the standard program — the real 4-week program cost starts at $165.90/mo, over 4x the teaser figure
  • Weight care is not Midi's core identity — it's layered onto a menopause/HRT platform, so patients whose only need is GLP-1 may find a weight-loss-only provider more streamlined
  • No flat cash price is published for brand-name Wegovy/Zepbound — those go through the patient's own pharmacy/insurance, so actual cost is unknown until benefits are checked
  • Highest dose tiers get expensive fast: $355.00/mo for semaglutide at 2.5mg and $434.00/mo for tirzepatide at 13.75-15mg

The bottom line

Best for: Cost-first shoppers who want women already managing menopause who want their GLP-1 prescriber on the same platform, with no separate membership fee. Midi Health is a telehealth platform built around midlife women's hormone health (menopause, HRT) that also runs a genuine GLP-1 weight-management track with its own dedicated pricing page.

Ranked #308 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Midi Health.

The 24 programs nearest this one

Pricing, states and verification reflect Midi Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Midi Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard